LSERS
ACOR

Louisiana State Employees Retirement System’s Acorda Therapeutics ACOR Stock Holding History

Louisiana State Employees Retirement System’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-110
Closed -$10K – 1455
2020
Q2 		$10K Hold
110
– – ﹤0.01% 1338
2020
Q1 		$12K Sell
110
-27
-20% -$5.32K ﹤0.01% 1288
2019
Q4 		$33K Sell
137
-11
-7% -$2.78K ﹤0.01% 1431
2019
Q3 		$51K Buy
148
+24
+19% +$13K ﹤0.01% 1424
2019
Q2 		$99K Buy
124
+1
+0.8% +$1.23K 0.01% 1415
2019
Q1 		$197K Sell
123
-1
-0.8% -$1.8K 0.01% 1382
2018
Q4 		$231K Sell
124
-21
-14% -$45.7K 0.01% 1315
2018
Q3 		$342K Sell
145
-31
-18% -$96K 0.01% 1315
2018
Q2 		$606K Buy
176
+3
+2% +$9.19K 0.03% 1025
2018
Q1 		$492K Buy
173
+5
+3% +$15K 0.02% 1112
2017
Q4 		$431K Buy
168
+10
+6% +$28.4K 0.02% 1184
2017
Q3 		$447K Hold
158
– – 0.02% 1145
2017
Q2 		$374K Hold
158
– – 0.02% 1211
2017
Q1 		$397K Buy
158
+4
+3% +$11.5K 0.02% 1171
2016
Q4 		$348K Sell
154
-16
-9% -$38K 0.02% 1224
2016
Q3 		$426K Hold
170
– – 0.02% 1115
2016
Q2 		$520K Buy
170
+1
+0.6% +$3.25K 0.03% 967
2016
Q1 		$537K Buy
169
+10
+6% +$41.5K 0.03% 959
2015
Q4 		$817K Buy
159
+1
+0.6% +$4.37K 0.04% 627
2015
Q3 		$501K Hold
158
– – 0.03% 993
2015
Q2 		$633K Buy
158
+2
+1% +$7.73K 0.03% 899
2015
Q1 		$622K Sell
156
-7
-4% -$32.1K 0.03% 911
2014
Q4 		$801K Buy
163
+3
+2% +$12.9K 0.04% 734
2014
Q3 		$650K Sell
160
-1
-0.6% -$3.75K 0.03% 851
2014
Q2 		$651K Buy
161
+2
+1% +$8.15K 0.03% 898
2014
Q1 		$724K Hold
159
– – 0.03% 801
2013
Q4 		$558K Buy
+159
New +$620K 0.03% 981

Other funds holding ACOR

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Louisiana State Employees Retirement System's ACOR Position: Q3 2020 in Review

Louisiana State Employees Retirement System sold out of Acorda Therapeutics (ACOR) in Q3 2020, closing a stake of 110 shares — an estimated $10K sold.

Louisiana State Employees Retirement System first reported a position in ACOR in Q4 2013 and held it in 27 quarters. The position peaked at $817K in Q4 2015. 60 funds tracked by Wall St. Rank hold ACOR as of Q3 2020.

  • Louisiana State Employees Retirement System reported no remaining Acorda Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 110 Acorda Therapeutics shares in Q3 2020, an estimated $10K.
  • Louisiana State Employees Retirement System first reported a position in Acorda Therapeutics in Q4 2013 and held it in 27 quarters.
  • Louisiana State Employees Retirement System's Acorda Therapeutics position peaked at $817K in Q4 2015.
  • 60 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2020.

Based on Louisiana State Employees Retirement System's 13F filing for Q3 2020, filed 19 Oct 2020.